Recent Comments

Health-care reform bills continue to benefit illegal aliens (4)
Leslie wrote: In response to your comment on deporting every las… [More]
FDA approves Xiaflex drug for treatment of Dupuytren's contracture (1)
Jay Ryan wrote: Is this procedure available yet in NY? [More]
Health care reform bill will disrupt dental coverage of more than 441,000 Virginia children (1)
David Urban wrote: Despite claims to the contrary, in essence, Delta … [More]
Effects of Taser on human health (3)
Ed wrote: Is there any study or facts about tasers effecting… [More]
Three key responses behind food neophobia, the rejection of new foods in both adults and children (2)
Tommy wrote: You've just described exactly what I am going thro… [More]
Okay girls, relax, 20.85 is now the perfect body! (2)
Erin wrote: Well, for one, your chart is way off. I am 20 year… [More]
Simbionix launches advanced simulator for GI endoscopy and flexible bronchoscopy training (1)
Dr R abindranath Das wrote: From: Dr.R.N.Das, MBBS(Cal),MD(PGI,MRCP(UK),FRCP(L… [More]

<< Homelessness declines in Los Angeles; recession pave way for affordable housing | Open enrollment for seniors to select healthcare coverage for 2010 to begin in November >>

Dysport drug for treatment of cervical dystonia launched in the United States

29. October 2009 02:24

Ipsen (Paris: IPN), an innovation-driven global specialty pharmaceutical group, today announced that Dysport^®is now available in the United States for the treatment of cervical dystonia in adults.

Dysport^® is the latest addition to the growing range of Ipsen’s drugs already available in North America, both in endocrinology with Somatuline^® Depot and Increlex^®, and in neurology, with Apokyn^®.

Christophe Jean, Executive Vice President, Operations of the Ipsen Group said: “The launch of Dysport^® in its therapeutic indication for the treatment of cervical dystonia in the United States is undoubtedly a significant milestone to strengthen Ipsen's presence in North America. We are very pleased to be able to offer physicians a new and important treatment option for their patients suffering from cervical dystonia. Dysport^®, together with Somatuline^® and Increlex^®, becomes Ipsen’s third product to be available globally. With the achievement of this key milestone, I wish to congratulate and thank the teams that are making this launch a reality thanks to their hard work and dedication reflective of an efficient organization.”

Source: Ipsen

85634774-3916-440d-bc2a-1085efd880bb|0|.0

Posted in: Pharmaceutical News

Tags: Allergy, Dysport, Dystonia, Education, Endocrinology, Headache, Hypersensitivity, Neurology, Oncology, Posture, Speech

Online patient support program for ADHD patients taking Vyvanse Capsules CII medicationShire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, today announced...AltaMed Health Services opens its newest Adult Day Health Care center in CypressAltaMed Health Services Corporation, elected officials and community leaders came together today to ...Transient ischemic attack can trigger strokeOne out of every eight strokes is preceded by a "warning stroke," which is a transient ischemic atta...European CHMP recommends Merck's JANUVIA and JANUMET as add-on to insulinMerck & Co., Inc., which operates in many countries as Merck Sharp & Dohme (MSD), has received a pos...Children with microcephaly should be screened for neurologic and cognitive problems, says guidelineA new guideline from the American Academy of Neurology, developed in full collaboration with the Chi...Details about Ob/Gyn and Abdominal Sonography course released by Research and MarketsResearch and Markets(http://www.researchandmarkets.com/research/567f1d/obgyn_and_abdomin) has announ...Report on prescription drugs in worldwide marketsReportlinker.com announces that a new market research report is available in its catalogue. Prescrip...New car design for pregnant mothersUK researchers have developed a new computer model - Expecting - that can be used as a design tool f...Preventing lung scarring may extend lives of lung cancer patientsResearchers have found that using a special type of drug called a pharmaceutical monoclonal antibody...Prebiotics in infants for prevention of allergic disease and food hypersensitivityMany parents add prebiotics and probiotics to children's food to help treat health problems, and acc...New hope for insulin dependent diabetes cureA diagnosis of type I diabetes means a life sentence of medical follow-up.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.

Add comment

Quirky Comment Title
Name*
E-mail* (Will show your Gravatar icon)
Country Country flag

b i u quote

Comment
Preview

Notify me when new comments are added

Leave this field blank

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

Free!

Recent Comments

Twitter

Information

Dysport drug for treatment of cervical dystonia launched in the United States

Recent Articles

New Articles

Free!

Recent Comments

Twitter

Information

Dysport drug for treatment of cervical dystonia launched in the United States

Medical News Cloud

Recent Articles

New Articles